Key terms
About ASMB
Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses on two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ASMB news
Apr 03
1:52am ET
Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Natera (NTRA) and Disc Medicine (IRON)
Apr 01
6:36am ET
H.C. Wainwright Sticks to Its Hold Rating for Assembly Biosciences (ASMB)
Mar 28
4:13pm ET
Assembly Biosciences reports FY23 EPS ($13.38) vs. ($23.08) last year
Mar 15
4:24pm ET
Assembly Biosciences Welcomes New Board Member, Launches Bonus Plan
Feb 13
4:33pm ET
Assembly Biosciences Executes Reverse Stock Split
Feb 09
7:50pm ET
Assembly Biosciences trading halted, news pending
Feb 08
8:12am ET
Assembly Biosciences to effect 1-for-12 reverse stock split on February 9
Jan 04
8:13am ET
Assembly Biosciences provides anticipated development milestones for 2024
No recent news articles are available for ASMB
No recent press releases are available for ASMB
ASMB Financials
Key terms
Ad Feedback
ASMB Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ASMB Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
